Author Archives: Angelos Athanasopoulos

Home / Articles posted by Angelos Athanasopoulos

EAHAD Gene Therapy Working Group launches

EAHAD is pleased to announce the formation of a Working Group on Gene Therapy, following the approval of a proposal to the Executive Committee in September. Chaired by Prof. Dr Wolfgang Miesbach, the Working Group will have a mandate of two years and will be comprised of six to eight members. A patient representative will also be invited to take part.read more…

Access the EAHAD Factor VII Gene (F7) Variant Database

By Emeritus Prof. Christopher Ludlam and Prof. John McVey, EAHAD-DB Coagulation Factor Variant Database Steering Group

 

The updated EAHAD Factor VII Gene (F7) Variant Database is now available at www.f7-db.eahad.org

 

The database now includes 221 unique variants, representing gene variants identified in 728 individuals. read more…

EAHAD 2020: Just 2 months away!

EAHAD 2020 is taking place from 4-7 February under the direction of Congress President, Prof. Dr. Karin Fijn van Draat. The theme of this year’s Congress is “A Golden Age of Treatment Choice”.read more…

Interview with Prof. Dr. Karin Fijn van draat, EAHAD 2020 President

Prof. Dr. Karin Fijn van Draat is not only a member of the EAHAD Executive Committee, but also the President of our 2020 Congress taking place from 5 to 7 February 2020 in The Hague, Netherlands. In the lead up to our 13th annual meeting, we had the opportunity to speak with Prof. Fijn van Draat about her background, the most rewarding and challenging aspects of being this year’s Congress President, as well as her views on what the future key issues will be in the haemophilia and allied disorders field in Europe.read more…

The EAHAD Psychosocial Group looks for a social worker to join

The EAHAD Psychosocial Professionals Working Group currently has one vacant spot and is inviting social workers involved in haemophilia and bleeding disorders care to apply. The position is for a three-year term that would begin in 2020.read more…

EAHAD Executive Committee: Call for Nominations

EAHAD is inviting its members to apply for 4 vacant spots on its Executive Committee.
read more…

2020 EAHAD membership – Join us!

The 2020 EAHAD membership cycle has just been launched! Benefits for new and returning members range from reduced registration fees for the EAHAD 2020 Congress; a one-year subscription to Haemophilia Journal, combining online access and six issues sent by post; regular updates on EAHAD activities and initiatives, including three annual issues of our newsletter; as well as eligibility to join our committees and vote at the Annual General Meeting.
read more…

Visiting Manchester Central, EAHAD 2021 Congress venue

On 19 September, EAHAD representatives were in Manchester, UK, host city for our 2021 Congress. The delegation included EAHAD President, Prof Mike Makris, who will serve as Congress President for EAHAD 2021.
read more…

EAHAD’s Psychosocial Group looks into the future of psychosocial care

Continuing their pursuit of building a community of psychologists and social workers involved in the bleeding disorders field in Europe, the EAHAD Psychosocial Professionals Working Group will dedicate the third and final part of their EAHAD 2020 Pre-Congress Day Programme to a brainstorming session on building a network of European peers and colleagues.
read more…

Save the date! – EAHAD 2020 in The Hague from 5-7 February

The EAHAD 2020 Annual Congress will take place in The Hague, Netherlands, from 5 to 7 February 2020 at the World Forum congress centre.

 

Congress President Prof. Karin Fijn van Draat, with the support of the Congress Organising Committee, has put together an insightful programme, full of interesting sessions on the most pressing issues in haemophilia and bleeding disorders care today. With the theme “A Golden Age for Treatment Choice”, the programme pays homage to Dutch history and the legacy of 17th century art on display in The Hague, while highlighting the exciting period we find ourselves in in terms of haemophilia treatment and the many considerations that clinicians and patients must take into account.
read more…